NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

114 hedge funds and large institutions have $730M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 20 closing their positions.

Holders
114
Holders Change
-5
Holders Change %
-4.2%
% of All Funds
1.8%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
15
Increased
38
Reduced
40
Closed
20
Calls
$41K
Puts
–
Net Calls
+$41K
Net Calls Change
-$1.54M

Top Buyers

1
CG
1
Column Group
California
$248M
2
EC
2
EcoR1 Capital
California
$8.25M
3
WP
3
Woodline Partners
California
$7.18M
4
Morgan Stanley
4
Morgan Stanley
New York
$8.86M
5
FLAM
5
First Light Asset Management
Minnesota
$12.5M

Top Sellers

1
RG
1
Redmile Group
California
$0
2
LGM
2
Logos Global Management
California
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$2.41M
4
Millennium Management
4
Millennium Management
New York
$6.37M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$2.25M
Name Holding Trade Value Shares
Change 		Shares
Change %
Northern Trust
26
Northern Trust
Illinois
$4.47M -$174K -11,408 -4%
BBA
27
Baker Bros. Advisors
New York
$4.45M – – –
HWAM
28
Hennion & Walsh Asset Management
New Jersey
$3.76M -$159K -10,436 -4%
Nuveen Asset Management
29
Nuveen Asset Management
Illinois
$3.75M -$133K -8,734 -3%
CS
30
Candriam SCA
Luxembourg
$3.31M +$3.31M +217,187 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$2.97M -$1.1M -72,400 -27%
SAM
32
Silvercrest Asset Management
New York
$2.88M +$26.9K +1,762 +0.9%
Deutsche Bank
33
Deutsche Bank
Germany
$2.62M +$55.7K +3,650 +2%
Goldman Sachs
34
Goldman Sachs
New York
$2.5M -$654K -42,896 -21%
Citadel Advisors
35
Citadel Advisors
Florida
$2.41M -$8.18M -536,354 -77%
Renaissance Technologies
36
Renaissance Technologies
New York
$2.37M +$1.24M +81,000 +108%
Two Sigma Investments
37
Two Sigma Investments
New York
$2.25M -$1.36M -89,461 -38%
Lord, Abbett & Co
38
Lord, Abbett & Co
New Jersey
$2.03M -$799K -52,375 -28%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.02M +$59.4K +3,893 +3%
DCM
40
DAFNA Capital Management
California
$1.64M +$414K +27,168 +34%
Norges Bank
41
Norges Bank
Norway
$1.45M +$1.45M +95,400 New
CSS
42
Cubist Systematic Strategies
Connecticut
$1.24M +$312K +20,464 +34%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.12M +$90K +5,900 +9%
PAM
44
Panagora Asset Management
Massachusetts
$1.11M +$87.7K +5,750 +9%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$967K +$51.3K +3,366 +6%
RJA
46
Raymond James & Associates
Florida
$959K +$959K +62,888 New
SG Americas Securities
47
SG Americas Securities
New York
$887K -$267K -17,510 -23%
Invesco
48
Invesco
Georgia
$842K +$50.5K +3,313 +6%
Allianz Asset Management
49
Allianz Asset Management
Germany
$733K +$733K +48,070 New
HS
50
HighVista Strategies
Massachusetts
$705K +$705K +46,243 New
1
2
3 4 5